Viewing Study NCT06237335


Ignite Creation Date: 2025-12-24 @ 10:02 PM
Ignite Modification Date: 2025-12-25 @ 7:39 PM
Study NCT ID: NCT06237335
Status: RECRUITING
Last Update Posted: 2025-11-17
First Post: 2024-01-23
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Phase 2 Study Evaluating Safety and Tolerability of RCT2100 (CFTR mRNA) in Healthy Participants and in Participants With CF
Sponsor: ReCode Therapeutics
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module